3 ms·
The Lancet article says that one patient died of complications with the transplant procedure, and this was Phase 2. I'm in pharma, not stem cells, but if a pati
by jonlucc 10y ago
The Lancet article says that one patient died of complications with the transplant procedure, and this was Phase 2. I'm in pharma, not stem cells, but if a patient died due to treatment, the project would be killed. Perhaps the transplant procedure is well-understood along with its risks (I assume you have to transplant into the CNS?), but even oncology drugs aren't allowed to kill patients anymore.
- lostlogin 10y agoNo, not into CNS. It is a well established procedure, is more than a little rough. "Those stem cells were then purified, wiped of any memory of the disease, to later be transplanted into Molson through a blood transfusion."